(KCH) Krakchemia - Ratings and Ratios

Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock • ISIN: PLKRKCH00019

KCH: Plastic, Chemicals, Reagents, Filters, Standards

Krakchemia S.A. is a Poland-based company specializing in the wholesale trade of chemical products, serving both domestic and international markets. Established in 1945, the company has a long-standing presence in the chemical distribution sector and operates through two primary segments: Wholesale and Other Activities. Its product portfolio includes a wide range of chemical raw materials such as polyethylene, polypropylene, and styrene fibers, catering to industries like automotive, construction, and manufacturing. Additionally, Krakchemia provides chemical reagents, laboratory equipment, and packaging solutions, making it a comprehensive supplier in the specialty chemicals space. The company also engages in real estate investments and property rental activities, diversifying its revenue streams beyond its core business. Krakchemia S.A. is headquartered in Kraków, Poland, and has been listed on the Warsaw Stock Exchange under the ticker symbol KCH since its renaming in 2004.

From a technical standpoint, Krakchemias stock (WAR:KCH) has shown a price of 1.21 PLN as of the latest close, with a 20-day average volume of 65,292 shares. The stocks short-term trend, indicated by the 20-day SMA of 1.22, suggests a potential support level near 1.16, as indicated by the 50-day SMA. The 200-day SMA of 0.76 highlights the stocks upward trajectory over the past year. The ATR of 0.11 reflects moderate price volatility, suggesting that the stock may experience price swings within a narrow range in the near term.

On the fundamental side, Krakchemias market capitalization stands at 10.53 million PLN, with a price-to-book (P/B) ratio of 0.18, indicating that the stock may be undervalued relative to its book value. The price-to-sales (P/S) ratio of 0.22 suggests that the company is generating limited revenue per share of stock. However, the return on equity (RoE) of 20.38% highlights the companys ability to generate profits from shareholders equity, signaling strong operational efficiency.

3-Month Forecast: Based on the and , Krakchemias stock is expected to trade sideways in the near term, with potential resistance at the 1.25 level and support at 1.10. The relatively low ATR of 0.11 suggests that price movements will remain moderate, with limited upside or downside volatility. The stocks valuation metrics, particularly the low P/B ratio, may attract value investors, potentially driving slight upward momentum. However, the lack of earnings visibility, as indicated by the zero P/E ratio, could limit significant price appreciation. Overall, the stock is expected to remain range-bound, with a potential breakout above 1.25 if fundamental conditions improve.

Additional Sources for KCH Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

KCH Stock Overview

Market Cap in USD 2m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception

KCH Stock Ratings

Growth 5y 42.7%
Fundamental 13.8%
Dividend 0.10%
Rel. Strength 257
Analysts -
Fair Price Momentum 0.98 PLN
Fair Price DCF 2.36 PLN

KCH Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y 0.00%
Payout Consistency 0.4%

KCH Growth Ratios

Growth Correlation 3m -50.5%
Growth Correlation 12m 86%
Growth Correlation 5y -16.8%
CAGR 5y 22.76%
CAGR/Max DD 5y 0.31
Sharpe Ratio 12m -0.03
Alpha 198.99
Beta 0.134
Volatility 61.77%
Current Volume 43.9k
Average Volume 20d 16.5k
What is the price of KCH stocks?
As of April 09, 2025, the stock is trading at PLN 1.00 with a total of 43,877 shares traded.
Over the past week, the price has changed by -10.89%, over one month by -17.52%, over three months by -8.44% and over the past year by +200.60%.
Is Krakchemia a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Krakchemia is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 13.84 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KCH as of April 2025 is 0.98. This means that KCH is currently overvalued and has a potential downside of -2%.
Is KCH a buy, sell or hold?
Krakchemia has no consensus analysts rating.
What are the forecast for KCH stock price target?
According to ValueRays Forecast Model, KCH Krakchemia will be worth about 1.1 in April 2026. The stock is currently trading at 1.00. This means that the stock has a potential upside of +6%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 1.1 6%